Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
32.84
+1.37 (4.35%)
Feb 2, 2026, 4:00 PM EST

SHE:301281 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
74.83178.13325.22148.9766.0137.44
Short-Term Investments
--210.26---
Trading Asset Securities
251.91254.43150.54---
Cash & Short-Term Investments
326.74432.56686.02148.9766.0137.44
Cash Growth
-28.03%-36.95%360.50%125.69%76.29%10.48%
Accounts Receivable
99.8995.8575.8556.8743.7166.39
Other Receivables
15.3327.110.650.310.690.54
Receivables
115.23122.9676.557.1844.466.93
Inventory
151.08128.94108.0567.9286.4470.95
Other Current Assets
40.226.268.228.26.531.37
Total Current Assets
633.27690.73878.79282.27203.38176.7
Property, Plant & Equipment
569.03477314.2308.83290.27217.61
Long-Term Investments
192.61190.31184.08---
Goodwill
1.821.82----
Other Intangible Assets
114.47107.1746.0249.0851.7654.76
Long-Term Deferred Tax Assets
3.343.062.922.091.621.69
Long-Term Deferred Charges
3.032.390.731.733.154.45
Other Long-Term Assets
88.2779.9843.227.799.343.33
Total Assets
1,6061,5521,470651.79559.51458.53
Accounts Payable
47.5242.2550.1854.9860.5828.89
Accrued Expenses
12.6844.5939.7129.2323.6524.9
Current Income Taxes Payable
4.141.080-4.597.98
Current Unearned Revenue
3.920.243.53.023.0912.75
Other Current Liabilities
44.3111.6317.7520.6418.8325.26
Total Current Liabilities
112.55119.78111.14107.86110.7599.79
Long-Term Debt
97.5845.66----
Long-Term Unearned Revenue
9.159.2710.539.0410.1110.39
Long-Term Deferred Tax Liabilities
15.1217.7817.2515.167.666.72
Other Long-Term Liabilities
-0.38----
Total Liabilities
234.4192.87138.93132.06128.52116.9
Common Stock
108.29108.29108.29585858
Additional Paid-In Capital
907.67907.67909.97195.34195.34186.45
Retained Earnings
350.08340.26312.3266.2174.9396.75
Comprehensive Income & Other
4.812.570.480.192.720.43
Total Common Equity
1,3711,3591,331519.73430.98341.63
Minority Interest
0.60.81----
Shareholders' Equity
1,3711,3601,331519.73430.98341.63
Total Liabilities & Equity
1,6061,5521,470651.79559.51458.53
Total Debt
97.5845.66----
Net Cash (Debt)
229.16386.9686.02148.9766.0137.44
Net Cash Growth
-49.52%-43.60%360.50%125.69%76.29%-
Net Cash Per Share
2.133.596.771.830.810.46
Filing Date Shares Outstanding
108.29108.29108.2981.281.281.2
Total Common Shares Outstanding
108.29108.29108.2981.281.281.2
Working Capital
520.73570.95767.65174.492.6476.91
Book Value Per Share
12.6612.5512.296.405.314.21
Tangible Book Value
1,2551,2501,285470.65379.23286.88
Tangible Book Value Per Share
11.5911.5411.875.804.673.53
Buildings
-216.15213.26208.05186.34152.37
Machinery
-342.54316.21275.82210.37193.11
Construction In Progress
-183.1512.1519.9966.2322.28
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.